<?xml version="1.0" encoding="UTF-8"?>
<p id="par0025">Currently, no corona virus-specific therapeutic agent, monoclonal antibodies, or vaccine has been approved. Thus, there is an urgent need for effective medication and vaccine for COVID-19 disease to limit the transmission in the community. Most treatment options for COVID-19 taken from previous experiences in treating SARS-CoV, MERS CoV, and other viral diseases.
 <xref rid="bib0505" ref-type="bibr">
  <sup>11</sup>
 </xref> Currently, mechanical ventilation, ICU admission, and supportive care are the most important management strategy for severe cases. According to WHO guidelines infected patients treated with supportive care like bed rest, oxygen saturation, adequate nutrition, prevention of dehydration, keeping electrolyte and acid-base balance, antibiotics, and isolation of patients suspected or confirmed for COVID-19.
 <xref rid="bib0510" ref-type="bibr">
  <sup>12</sup>
 </xref> Several pre-existing and potential drug candidates, including remdesivir, chloroquine, and others are considered. the Therapeutic options that could be evaluated and used for COVID-19 include molecules binding to the virus, inhibiting enzymes involved in viral replication and transcription, inhibitors targeting helicase and proteases, host cell protease inhibitors, host cell endocytosis inhibitors, anti-sense RNA and ribozyme, neutralizing antibodies, mAbs targeting host cell receptor or interfere with S1 RBD, antiviral peptide targeting S2, and natural products.
 <xref rid="bib0515" ref-type="bibr">
  <sup>13</sup>
 </xref>
</p>
